Skip to content

Clinical trials

Phase 1 Prostatic Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1 Country / region: Australia Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20152
20162
20171
20192
20205
20214
20224
20236
20247
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting16
Completed15
Active, not recruiting7
Terminated6
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen5
Eli Lilly and Company3
AstraZeneca2
Atridia Pty Ltd.2
Novartis Pharmaceuticals2
Telix Pharmaceuticals (Innovations) Pty Limited2
3B Pharmaceuticals GmbH1
Alpha-9 Oncology USA Inc.1
Alterome Therapeutics, Inc.1
Aptevo Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms46
Breast Neoplasms14
Ovarian Neoplasms12
Pancreatic Neoplasms8
Neoplasms7
Urinary Bladder Neoplasms6
Colorectal Neoplasms5
Melanoma5
Neoplasm Metastasis5
Triple Negative Breast Neoplasms5

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.